AML16 2nd Amendment May 2006

N.B. Principal Investigators, please inform your R&D department of this latest AML16 amendment.

AML16 Protocol Version 5, May 2006

Patient Information Sheet and Consent Form 1
1st Intensive Randomisation (Version 4 May 2006)

Patient Information Sheet and Consent Form 2
1st Non-Intensive Randomisation (Version 4 May 2006)

GP Letter AML16 Non-Intensive (Version 2 May 2006)

Summary of Current Versions of AML16 Trial Documentation

MREC Amendment Approval Letter

MREC Notification of Substantial Amendment

MREC Covering Letter

MHRA Amendment Approval Letter

Protocol Version 5 May 2006 MREC Typo Approval Letter

Summary of Changes

Summary of Actions Needed

Confirmation of Notification Form